NORTH KINGSTOWN, R.I., Nov. 29, 2017 /PRNewswire/ -- In 2017, Dominion Diagnostics, LLC celebrated two decades as one of the country's leading drug monitoring companies. Delivering the highest level of commitment to compliance, quality, innovative technology and tools, clinically relevant education and customer support has led them to be a premier choice in laboratory testing for the addiction treatment, behavioral health, and pain management fields. The work they do results in actionable data and custom clinical tools that inform patient treatment and advance the quality of care.
Dominion Diagnostics employs over 300 nationally diverse individuals whose expertise drives new solutions to the challenges its customers face daily. In two of the last three years, Dominion Diagnostics has been recognized among the Best Places to Work in Rhode Island (2015, 2017). The company has also been honored for three consecutive years as one of the Healthiest Employers in Rhode Island, and has achieved exemplary winner status for two consecutive years in the Blue Cross Blue Shield of Rhode Island Worksite Health Awards.
"Our employees are the foundation of our Company; it's thanks to our people that we have grown and thrived for over two decades doing this important work," says Bob Garvey, Dominion Diagnostics Chief Executive Officer. "There will be challenges and learnings that lie ahead of us for the next 20 years – with respect to regulatory changes and guidance, the growing concerns related to our nation's opioid epidemic and evolving drug use trends – but with our team and our experience, we are ready for those and we will continue to focus on delivering positive outcomes to patients' lives."
Dominion Diagnostics is headquartered in a 50,000-square foot state-of-the-art laboratory in North Kingstown, Rhode Island (located within the Quonset Development Corporation network) and delivers the vast majority of its services through Rhode Island. Two additional laboratories in Williston, Vermont and Greensboro, North Carolina allow for dedicated regional support in both the Northeast and Southeast. Critical national logistics and supply partnerships, as well as numerous patient service center locations, allow Dominion to support the expanding needs of its customers who represent like-minded addiction treatment centers, behavioral health facilities, pain management practices, primary care practices and hospital systems.
"Congratulations to Dominion Diagnostics on 20 successful years," said Steven King, P.E., Managing Director of the Quonset Development Corporation. "These kind of successful companies are what makes the Quonset Business Park the leading engine of job growth in Rhode Island."
In 1997, a group of scientists recognized a need to deliver a higher standard of drug testing than was available at the time and founded Dominion Diagnostics with special interest in the addiction medicine field. The small start-up team of three missioned "to discover, develop and perform diagnostic laboratory procedures that improve the quality of life." Now twenty years later, Dominion's services span across more than 75% of the United States and have touched the lives of millions of patients and their families – in fact, just this year alone the company will reach a milestone of testing over one million unique patient samples – most of whom were affected by the ever-expanding national drug use epidemic. Compounding its history, Dominion's expert research and development team has over 40 years of combined experience in bioanalytical method development and validation, affording the company a leading edge in proprietary method development and discovery to address emerging needs in patient care.
For more information about Dominion Diagnostics, please visit www.dominiondiagnostics.com.
Press Contact: Julie Lenahan, email@example.com, 401.667.0876
SOURCE Dominion Diagnostics, LLC